This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  86R13084 JG-F
 
  By: Hall S.B. No. 2350
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the prohibited administration of certain vaccinations.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter A, Chapter 161, Health and Safety
  Code, is amended by adding Section 161.0045 to read as follows:
         Sec. 161.0045.  ADMINISTRATION OF CERTAIN VACCINES
  PROHIBITED. A health care provider may administer a vaccine only
  if:
               (1)  the study relied on by the United States Food and
  Drug Administration for approval of the vaccine evaluated the
  safety of the vaccine against a control group that received:
                     (A)  a placebo; or
                     (B)  another vaccine or other substance approved
  by the United States Food and Drug Administration based on a study
  that evaluated the safety of that vaccine or substance against a
  control group that received a placebo for that study;
               (2)  the study relied on by the United States Food and
  Drug Administration for approval of the vaccine evaluated the
  safety of the vaccine for a sufficient time to identify potential
  autoimmune, neurological, or chronic health conditions that may
  arise on or after the first anniversary of the date the vaccine is
  administered;
               (3)  the vaccine has been evaluated for the vaccine's
  potential to:
                     (A)  cause cancer;
                     (B)  mutate genes;
                     (C)  affect fertility or cause infertility; and
                     (D)  cause autism spectrum disorder;
               (4)  the department has posted on the department's
  Internet website a disclosure of any known injuries or diseases
  caused by the vaccine and the rate at which the injuries or diseases
  have occurred; and
               (5)  the chemical, pharmacological, therapeutic, and
  adverse effects of the vaccine and the rate of injury of the vaccine
  when administered with other vaccines have been studied and
  verified.
         SECTION 2.  This Act takes effect September 1, 2019.